The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2025 | What is the role of surgery is in pleural mesothelioma?
Isabelle Schmitt-Opitz, MD, University Hospital Zurich, Zurich, Switzerland, emphasizes the potential role of surgery in early-stage mesothelioma, particularly in epithelioid subtypes. Despite results from the MARS 2 trial (NCT02040272), surgery should not be entirely ruled out from the treatment landscape, but current biomarkers may not be sufficient to identify patients best suited for surgery. This interview took place at the European Lung Cancer Congress (ELCC) 2025 in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
